[Form 4] HealthStream Inc Insider Trading Activity

Rhea-AI Filing Summary

HealthStream Inc. executive Kevin P. O'Hara reported the sale of 2,000 shares of the company's common stock on 08/27/2025, at a weighted average price of $27.9679 per share (individual trades ranged from $27.79 to $28.10). After the sale, Mr. O'Hara beneficially owned 17,137 shares. The Form 4 identifies Mr. O'Hara as an Executive Vice President and officer of the issuer and shows the filing was signed on 08/27/2025. The disclosure includes an agreement to provide trade-level detail on request and contains no derivative transactions or other securities reported on this form.

Positive

• Timely SEC disclosure filed and signed, documenting the insider transaction and offering to provide trade-level details on request
• No derivative activity reported on this Form 4, limiting complexity of the disclosure

Negative

• Insider sale of 2,000 shares on 08/27/2025, reducing beneficial ownership to 17,137 shares
• Weighted average price reported rather than trade-level prices (individual trades ranged $27.79–$28.10), which requires request for full detail

Insights

Securities Analyst

TL;DR Insider sale of 2,000 HSTM shares by an executive; routine reporting with no derivatives disclosed.

Kevin P. O'Hara, an Executive Vice President and reporting person, disposed of 2,000 shares on 08/27/2025 at a weighted average price of $27.9679, reducing his beneficial ownership to 17,137 shares. The filing follows Section 16 reporting requirements and includes an explanatory note that the reported price is a weighted average across multiple trades between $27.79 and $28.10. There are no option exercises, grants, or other derivative transactions reported on this Form 4. This appears to be a standard insider sale disclosure without additional material events.

Corporate Governance Expert

TL;DR Timely, compliant Form 4 filing documenting an executive sale; no governance red flags present in the disclosure.

The report is signed and dated 08/27/2025 and explicitly states the reporting person's role as Executive Vice President. The explanatory footnote commits to providing trade-level details upon request, which supports transparency. No indications of related-party transactions, plan-based sales (no 10b5-1 box checked), or concurrent derivative activity are present. From a governance perspective, the document meets basic SEC disclosure standards and contains no immediate compliance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Hara Kevin P

(Last) (First) (Middle)

500 11TH AVENUE NORTH

SUITE 850

(Street)

NASHVILLE TN 37203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHSTREAM INC [ HSTM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock Holding	08/27/2025		S		2,000	D	$27.9679(1)	17,137	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $27.79 to $28.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

	/s/ Kevin P. O'Hara	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kevin P. O'Hara report in the HSTM Form 4?

The filing reports a sale of 2,000 HealthStream (HSTM) shares on 08/27/2025, with a weighted average sale price of $27.9679, leaving him with 17,137 shares.

When were the HSTM shares sold and at what price?

The shares were sold on 08/27/2025 at a weighted average price of $27.9679; individual trade prices ranged from $27.79 to $28.10.

Does the Form 4 show any option exercises or derivative transactions for HSTM?

No. The Form 4 contains no derivative security transactions; it reports only a non-derivative sale of common stock.

What is Kevin P. O'Hara's role at HealthStream as stated on the form?

The form identifies Kevin P. O'Hara as an Executive Vice President and officer of HealthStream.

Is additional trade detail available for the reported HSTM sale?

Yes. The filing states the price shown is a weighted average and the reporting person "undertakes to provide upon request" full trade-level share counts and prices to the SEC staff, issuer, or a security holder.